Importantly, the OVA257-264-specific CD8+ T cells generated in NAFLD do not show obvious functional impairment, which suggests the impaired anti-tumor immunity is caused by the changed liver immune environment. The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatotic liver disease.